Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Jul 20, 2018
Financial News
Provention raises $64M IPO
...Thursday through the sale of 16 million shares at $4 in an IPO underwritten by
MDB Capital Group
...
Read More
BioCentury
|
Jul 20, 2018
Financial News
Provention raises $64M IPO
...19 through the sale of 16 million shares at $4 in an IPO underwritten by
MDB Capital Group
...
Read More
BioCentury
|
May 11, 2018
Financial News
Provention plans IPO, reveals MacroGenics deal
...proposed on May 9 to raise up to $50 million in an IPO underwritten by
MDB Capital Group
...
Read More
BioCentury
|
May 10, 2018
Financial News
Provention plans IPO, reveals MacroGenics deal
...Inc. (Lebanon, N.J.) proposed to raise up to $50 million in an IPO underwritten by
MDB Capital Group
...
Read More
BioCentury
|
Jan 5, 2018
Financial News
Autoimmune company Cue raises $66.2 million IPO
...2 through the sale of 8.8 million shares at $7.50 in an IPO underwritten by
MDB Capital Group
...
Read More
BioCentury
|
Jan 2, 2018
Financial News
Cue spikes after pricing $66.2M IPO
...million through the sale of 8.8 million shares at $7.50 in an IPO underwritten by
MDB Capital Group
...
Read More
BioCentury
|
Dec 8, 2017
Financial News
Cancer company Cue Biopharma updates IPO plans
...Cue filed in September to raise up to $40 million in an offering underwritten by
MDB Capital Group
...
Read More
BioCentury
|
Nov 17, 2017
Company News
Cue Biopharma in autoimmune deal with Merck
...Cue emerged from stealth mode in January with a $16.4 million venture round led by
MDB Capital Group
...
Read More
BioCentury
|
Sep 29, 2017
Financial News
Cue Biopharma proposes $40M IPO
...Mass.) proposed to raise up to $40 million in an IPO on NASDAQ underwritten by
MDB Capital Group
...
Read More
BioCentury
|
Sep 22, 2017
Financial News
Cue Biopharma proposes $40M IPO
...Mass.) proposed to raise up to $40 million in an IPO on NASDAQ underwritten by
MDB Capital Group
...
Read More
Items per page:
10
1 - 10 of 15
BioCentury
|
Jul 20, 2018
Financial News
Provention raises $64M IPO
...Thursday through the sale of 16 million shares at $4 in an IPO underwritten by
MDB Capital Group
...
Read More
BioCentury
|
Jul 20, 2018
Financial News
Provention raises $64M IPO
...19 through the sale of 16 million shares at $4 in an IPO underwritten by
MDB Capital Group
...
Read More
BioCentury
|
May 11, 2018
Financial News
Provention plans IPO, reveals MacroGenics deal
...proposed on May 9 to raise up to $50 million in an IPO underwritten by
MDB Capital Group
...
Read More
BioCentury
|
May 10, 2018
Financial News
Provention plans IPO, reveals MacroGenics deal
...Inc. (Lebanon, N.J.) proposed to raise up to $50 million in an IPO underwritten by
MDB Capital Group
...
Read More
BioCentury
|
Jan 5, 2018
Financial News
Autoimmune company Cue raises $66.2 million IPO
...2 through the sale of 8.8 million shares at $7.50 in an IPO underwritten by
MDB Capital Group
...
Read More
BioCentury
|
Jan 2, 2018
Financial News
Cue spikes after pricing $66.2M IPO
...million through the sale of 8.8 million shares at $7.50 in an IPO underwritten by
MDB Capital Group
...
Read More
BioCentury
|
Dec 8, 2017
Financial News
Cancer company Cue Biopharma updates IPO plans
...Cue filed in September to raise up to $40 million in an offering underwritten by
MDB Capital Group
...
Read More
BioCentury
|
Nov 17, 2017
Company News
Cue Biopharma in autoimmune deal with Merck
...Cue emerged from stealth mode in January with a $16.4 million venture round led by
MDB Capital Group
...
Read More
BioCentury
|
Sep 29, 2017
Financial News
Cue Biopharma proposes $40M IPO
...Mass.) proposed to raise up to $40 million in an IPO on NASDAQ underwritten by
MDB Capital Group
...
Read More
BioCentury
|
Sep 22, 2017
Financial News
Cue Biopharma proposes $40M IPO
...Mass.) proposed to raise up to $40 million in an IPO on NASDAQ underwritten by
MDB Capital Group
...
Read More
Items per page:
10
1 - 10 of 15
Previous page
Next page